Annual Current Liabilities
$71.32 M
+$17.43 M+32.35%
31 December 2023
Summary:
Poseida Therapeutics annual total current liabilities is currently $71.32 million, with the most recent change of +$17.43 million (+32.35%) on 31 December 2023. During the last 3 years, it has risen by +$41.29 million (+137.53%). PSTX annual current liabilities is now at all-time high.PSTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$78.27 M
-$24.16 M-23.59%
30 September 2024
Summary:
Poseida Therapeutics quarterly total current liabilities is currently $78.27 million, with the most recent change of -$24.16 million (-23.59%) on 30 September 2024. Over the past year, it has increased by +$1.30 million (+1.68%). PSTX quarterly current liabilities is now -23.59% below its all-time high of $102.43 million, reached on 30 June 2024.PSTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +32.4% | +1.7% |
| 3 y3 years | +137.5% | +146.2% |
| 5 y5 years | +447.6% | - |
PSTX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +137.5% | -23.6% | +146.2% |
| 5 y | 5 years | at high | +447.6% | -23.6% | +258.1% |
| alltime | all time | at high | +884.4% | -23.6% | +258.1% |
Poseida Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $78.27 M(-23.6%) |
| June 2024 | - | $102.43 M(+20.8%) |
| Mar 2024 | - | $84.76 M(+18.9%) |
| Dec 2023 | $71.32 M(+32.4%) | $71.32 M(-7.3%) |
| Sept 2023 | - | $76.97 M(+54.3%) |
| June 2023 | - | $49.89 M(+2.5%) |
| Mar 2023 | - | $48.69 M(-9.6%) |
| Dec 2022 | $53.88 M(+24.3%) | $53.88 M(+10.0%) |
| Sept 2022 | - | $48.97 M(+22.1%) |
| June 2022 | - | $40.09 M(-8.7%) |
| Mar 2022 | - | $43.92 M(+1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $43.34 M(+44.3%) | $43.34 M(+36.3%) |
| Sept 2021 | - | $31.80 M(-0.6%) |
| June 2021 | - | $32.00 M(+15.1%) |
| Mar 2021 | - | $27.79 M(-7.4%) |
| Dec 2020 | $30.02 M(+37.4%) | $30.02 M(+0.9%) |
| Sept 2020 | - | $29.77 M(+3.0%) |
| June 2020 | - | $28.89 M(-27.5%) |
| Mar 2020 | - | $39.85 M(+82.4%) |
| Dec 2019 | $21.86 M(+67.8%) | $21.86 M |
| Dec 2018 | $13.03 M(+79.8%) | - |
| Dec 2017 | $7.25 M | - |
FAQ
- What is Poseida Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Poseida Therapeutics?
- What is Poseida Therapeutics annual current liabilities year-on-year change?
- What is Poseida Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly current liabilities year-on-year change?
What is Poseida Therapeutics annual total current liabilities?
The current annual current liabilities of PSTX is $71.32 M
What is the all time high annual current liabilities for Poseida Therapeutics?
Poseida Therapeutics all-time high annual total current liabilities is $71.32 M
What is Poseida Therapeutics annual current liabilities year-on-year change?
Over the past year, PSTX annual total current liabilities has changed by +$17.43 M (+32.35%)
What is Poseida Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of PSTX is $78.27 M
What is the all time high quarterly current liabilities for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly total current liabilities is $102.43 M
What is Poseida Therapeutics quarterly current liabilities year-on-year change?
Over the past year, PSTX quarterly total current liabilities has changed by +$1.30 M (+1.68%)